Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Laren D Tan, Nolan Nguyen, Abdullah Alismail & Mario Castro. (2022) Management of Uncontrolled Asthma: A Framework for Novel and Legacy Biologic Treatments. Journal of Asthma and Allergy 15, pages 875-883.
Read now
Read now
Laren D Tan, Brett Schaeffer & Abdullah Alismail. (2019) Parasitic (Helminthic) Infection While on Asthma Biologic Treatment: Not Everything Is What It Seems. Journal of Asthma and Allergy 12, pages 415-420.
Read now
Read now
Marco Caminati, Diego Bagnasco, Rachele Vaia & Gianenrico Senna. (2019) New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic. Biologics: Targets and Therapy 13, pages 89-95.
Read now
Read now
Jenny Lam, Joel W. Hay, Jonathan Salcedo & Nicholas J. Kenyon. (2019) A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma. Journal of Asthma 56:8, pages 872-881.
Read now
Read now
Neil S. Skolnik & Sean P. Carnahan. (2019) Primary care of asthma: new options for severe eosinophilic asthma. Current Medical Research and Opinion 35:7, pages 1309-1318.
Read now
Read now
Takudzwa Mkorombindo & Mark T Dransfield. (2019) Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1779-1787.
Read now
Read now
Corrado Pelaia, Alessandro Vatrella, Andrea Bruni, Rosa Terracciano & Girolamo Pelaia. (2018) Benralizumab in the treatment of severe asthma: design, development and potential place in therapy. Drug Design, Development and Therapy 12, pages 619-628.
Read now
Read now
Laren D Tan, Nicholas Kenyon, Ken Y Yoneda & Samuel Louie. (2017) Bronchial thermoplasty: implementing best practice in the era of cost containment. Journal of Asthma and Allergy 10, pages 225-230.
Read now
Read now
Mitchell Goldman, Ian Hirsch, James G. Zangrilli, Paul Newbold & Xiao Xu. (2017) The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies. Current Medical Research and Opinion 33:9, pages 1605-1613.
Read now
Read now
Tara Vinyette Saco, Amber N. Pepper & Richard F. Lockey. (2017) Benralizumab for the treatment of asthma. Expert Review of Clinical Immunology 13:5, pages 405-413.
Read now
Read now
Articles from other publishers (44)
Efthymia Theofani, Aikaterini Tsitsopoulou, Ioannis Morianos & Maria Semitekolou. (2023) Severe Asthmatic Responses: The Impact of TSLP. International Journal of Molecular Sciences 24:8, pages 7581.
Crossref
Crossref
Christopher H. Fanta. (2022) Advances in Evaluation and Treatment of Severe Asthma (Part Two). Medical Clinics of North America 106:6, pages 987-999.
Crossref
Crossref
Ching-Yee Loo & Wing-Hin Lee. (2022) Nanotechnology-based therapeutics for targeting inflammatory lung diseases. Nanomedicine 17:12, pages 865-879.
Crossref
Crossref
Joanne Martin, Jennifer Townshend & Malcolm Brodlie. (2022) Diagnosis and management of asthma in children. BMJ Paediatrics Open 6:1, pages e001277.
Crossref
Crossref
Gurjit K. Khurana Hershey, Michael G. Sherenian & Tesfaye B. Mersha. 2022. Allergy Essentials. Allergy Essentials
25
39
.
David N. Pham. (2021) Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report. Journal of Medical Case Reports 15:1.
Crossref
Crossref
Deepak Timalsina, Krishna Prasad Pokhrel & Deepti Bhusal. (2021) Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations. BioMed Research International 2021, pages 1-23.
Crossref
Crossref
William W. Busse, Eugene R. Bleecker, J. Mark FitzGerald, Gary T. Ferguson, Peter Barker, Laura Brooks, Richard F. Olsson, Ubaldo J. Martin & Mitchell Goldman. (2021) Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment. Journal of Allergy and Clinical Immunology 148:1, pages 266-271.e2.
Crossref
Crossref
Mathieu Fieldes, Chloé Bourguignon, Said Assou, Amel Nasri, Aurélie Fort, Isabelle Vachier, John De Vos, Engi Ahmed & Arnaud Bourdin. (2021) Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Research 7:2, pages 00437-2020.
Crossref
Crossref
Masayuki Nakajima, Masashi Matsuyama, Naoki Arai, Hideyasu Yamada, Kentaro Hyodo, Mizu Nonaka, Haruna Kitazawa, Kazufumi Yoshida, Rie Shigemasa, Yuko Morishima, Takumi Kiwamoto, Hironori Masuko, Yukio Ishii, Masafumi Muratani, Takefumi Saito & Nobuyuki Hizawa. (2021) Identification of whole blood gene expressions correlated with responsiveness to benralizumab. Journal of Allergy and Clinical Immunology 147:2, pages 772-775.
Crossref
Crossref
Chad R. Marion, Manuel Izquierdo, Holly C. Hanes & Christopher Barrios. (2021) Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome. Current Allergy and Asthma Reports 21:2.
Crossref
Crossref
Marco Caminati, Diego Bagnasco, Lanny J. Rosenwasser, Andrea Vianello & Gianenrico Senna. (2020) Biologics for the Treatments of Allergic Conditions. Immunology and Allergy Clinics of North America 40:4, pages 549-564.
Crossref
Crossref
Andras Bikov, Ipek Kivilcim Oğuzülgen, Ilaria Baiardini, Marco Contoli, Alexander Emelyanov, Omar Fassio, Juan Carlos Ivancevich, Igor Kaidashev, Krzysztof Kowal, Marina Labor, Lies Lahousse, Stefan Mihaicuta, Silviya Novakova, Alicia Padilla Galo, Alexander Simidchiev, Angelica Tiotiu, Ignacio J. Ansotegui, Jonathan A. Bernstein, Louis Philippe Boulet, Giorgio Walter Canonica, Lawrence Dubuske, Nelson Rosario, Pierachille Santus, Fulvio Braido, Carmen Ardelean, Hector Badellino, Ariel Blua, Antonio Castillo, E. Carpagnano Giovanna, J. Chong-Neto Herberto, F. Daniel Colodenco, Dario Md Colombaro, Jaime Correia-De-Sousa, Fabiano Di Marco, Kunio Dobashi, Rocio Garcia, René Maximiliano Gomez, Olecsandr Gopko, Guillermo Guidos, Martina Hajduk, Joanna Hermanowicz-Salamon, Enrico Heffler, Bulent Karadag, Ali F. Kalyoncu, Metin Keren, Lykorguos Kolilekas, Marcelina Kocwin, Borislava Krusheva, Désirée Larenas Linnemann, Irine Litovchenko, A. Marcipar, L.E. Meza, D. Nedeva, P. Novakova, D. Plavec, S. Popović-Grle, F. Puggioni, L. Pur Oziygit, N. Rodrigez, D. Ryan, I. Ruzsics, N. Scichilone, F. Serpa, P. Steiropoulos, P. Solidoro, M. Turkalj, T. Umanets, C.F. Victorio, J.M. Zubeldia, V. Yachnyk & M. Zitt. (2020) Beliefs and preferences regarding biological treatments for severe asthma. World Allergy Organization Journal 13:7, pages 100441.
Crossref
Crossref
Stanislav Kan, Dewi Melani Hariyadi, Christopher Grainge, Darryl A. Knight, Nathan W. Bartlett & Mingtao Liang. (2020) Airway epithelial-targeted nanoparticles for asthma therapy. American Journal of Physiology-Lung Cellular and Molecular Physiology 318:3, pages L500-L509.
Crossref
Crossref
G. L. Ignatova, V. N. Antonov, E. V. Blinova, I. V. Grebneva & E. V. Sheklanova. (2020) New therapy options for patients with eosinophilic type of severe bronchial asthma. Medical Council:21, pages 111-116.
Crossref
Crossref
Ru Chen, Ke-xin Wang, Xue Meng & Wen Zhou. (2020) Does benralizumab effectively treat chronic obstructive pulmonary disease? A protocol of systematic review and meta-analysis. Medicine 99:20, pages e20241.
Crossref
Crossref
Ali Doroudchi, Mohini Pathria & Brian D. Modena. (2020) Asthma biologics. Annals of Allergy, Asthma & Immunology 124:1, pages 44-56.
Crossref
Crossref
Doreen E. Szollosi, Clinton B. Mathias & Jeremy P. McAleer. 2020. Pharmacology of Immunotherapeutic Drugs. Pharmacology of Immunotherapeutic Drugs
67
98
.
Efthymia Theofani, Maria Semitekolou, Ioannis Morianos, Konstantinos Samitas & Georgina Xanthou. (2019) Targeting NLRP3 Inflammasome Activation in Severe Asthma. Journal of Clinical Medicine 8:10, pages 1615.
Crossref
Crossref
Mohammed Al-Ayed, Khalid Alshaybari, Dhafer Alshehri, Alzahrani Jamaan, Iman Nasser, Hamdan Alaamri, Wed Alaseeri, Ahmed A. Mahfouz, Saeed Ali Alsareli, Ahmed Morad Asaad, Aamir Ali Magzoub, Mohamed Ansar Qureshi & Mohammed Helmy Shalayel. (2019) Obesity and childhood asthma in male schoolchildren in Saudi Arabia: Is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21?. Annals of Saudi Medicine 39:5, pages 295-301.
Crossref
Crossref
Jörg D. Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, Christophe von Garnier, Hans-Uwe Simon, Claudio Schuoler, Gunther Pendl & Markus Solèr. (2019) Benralizumab: Cibler le récepteur de l’IL-5 dans l’asthme sévère éosinophile. Praxis 108:7, pages 1-8.
Crossref
Crossref
Jörg D. Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, Christophe von Garnier, Hans-Uwe Simon, Claudio Schuoler, Gunther Pendl & Markus Solèr. (2019) Benralizumab: Der IL-5-Rezeptor als Ziel bei schwerem eosinophilem Asthma. Praxis 108:7, pages 469-476.
Crossref
Crossref
Seon Min Yoo & Sung Hyun Chung. (2018) Targets of monoclonal antibodies for immunological diseases. Archives of Pharmacal Research 42:4, pages 293-304.
Crossref
Crossref
José M. Rodrigo-Muñoz, José A. Cañas, Beatriz Sastre, Natalia Rego, Gonzalo Greif, Manuel Rial, Pablo Mínguez, Ignacio Mahíllo-Fernández, Mar Fernández-Nieto, Inés Mora, Pilar Barranco, Santiago Quirce, Joaquín Sastre & Victoria del Pozo. (2019) Asthma diagnosis using integrated analysis of eosinophil microRNAs. Allergy 74:3, pages 507-517.
Crossref
Crossref
Bao-Ping Tian, Fangyuan Li, Ruiqing Li, Xi Hu, Tian-Wen Lai, Jingxiong Lu, Yun Zhao, Yang Du, Zeyu Liang, Chen Zhu, Wei Shao, Wen Li, Zhi-Hua Chen, Xiaolian Sun, Xiaoyuan Chen, Songmin Ying, Daishun Ling & Huahao Shen. (2019) Nanoformulated ABT-199 to effectively target Bcl-2 at mitochondrial membrane alleviates airway inflammation by inducing apoptosis. Biomaterials 192, pages 429-439.
Crossref
Crossref
Jon Grace, Arjun Mohan & Njira Lucia Lugogo. (2019) Obesity and adult asthma. Current Opinion in Pulmonary Medicine 25:1, pages 44-50.
Crossref
Crossref
Sam Jackson, Albert F. Candia, Stephen Delaney, Simone Floettmann, Clifford Wong, John D. Campbell, Sariah Kell, Jeremy Lum, Edith M. Hessel, Paula Traquina, Mark McHale, Ian Robinson, John Bell, Rainard Fuhr, David Keeling & Robert L. Coffman. (2018) First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated. Clinical Pharmacology & Therapeutics 104:2, pages 335-345.
Crossref
Crossref
Brittany E Givens, Sean M Geary & Aliasger K Salem. (2018) Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma. Immunotherapy 10:7, pages 595-604.
Crossref
Crossref
Bradley E. Chipps, Paul Newbold, Ian Hirsch, Frank Trudo & Mitchell Goldman. (2018) Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma. Annals of Allergy, Asthma & Immunology 120:5, pages 504-511.e4.
Crossref
Crossref
Michael DreherTobias Müller. (2018) Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid. Tuberculosis and Respiratory Diseases 81:1, pages 1.
Crossref
Crossref
Corrado Pelaia, Cecilia Calabrese, Alessandro Vatrella, Maria Teresa Busceti, Eugenio Garofalo, Nicola Lombardo, Rosa Terracciano & Girolamo Pelaia. (2018) Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma. BioMed Research International 2018, pages 1-9.
Crossref
Crossref
L.‐T. Yang, Q. Shu, X.‐Q. Luo, Z.‐Q. Liu, S.‐Q. Qiu, J.‐Q. Liu, H.‐J. Guo, L.‐J. Li, M.‐G. Li, D.‐B. Liu, L.‐X. Xia, Z.‐G. Liu & P.‐C. Yang. (2017) Long‐term effects: Galectin‐1 and specific immunotherapy for allergic responses in the intestine. Allergy 73:1, pages 106-114.
Crossref
Crossref
Zhihao Fu, Chuanfei Yu, Lan Wang, Kai Gao, Gangling Xu, Wenbo Wang, Junxia Cao & Junzhi Wang. (2018) Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies. Journal of Pharmaceutical and Biomedical Analysis 148, pages 280-287.
Crossref
Crossref
Cameron H. Flayer, Sarah S. Killingbeck, Erik Larson, Zoulfia Allakhverdi & Angela Haczku. 2018. Immunopharmacology and Inflammation. Immunopharmacology and Inflammation
57
84
.
Tsutomu Yanagibashi, Mitsuo Satoh, Yoshinori Nagai, Masamichi Koike & Kiyoshi Takatsu. (2017) Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5. Cytokine 98, pages 59-70.
Crossref
Crossref
C.-Y. Choi, Y.-H. Kim, S. Oh, H.J. Lee, J.H. Kim, S.H. Park, H.J. Kim, S.J. Lee & T. Chun. (2017)
Anti-inflammatory potential of a heat-killed
Lactobacillus
strain isolated from Kimchi on house dust mite-induced atopic dermatitis in NC/Nga mice
. Journal of Applied Microbiology 123:2, pages 535-543.
Crossref
Crossref
Gary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, Michel Laviolette, David Bernstein, Craig LaForce, Lyndon Mansfield, Peter Barker, Yanping Wu, Maria Jison, Mitchell Goldman, Guy Chouinard, J Mark FitzGerald, Maryam Rostami, Jean Oosthuizen, Bonavuth Pek, Deepen Patel, Pierre-Alain Houle, Michel Laviolette, Sohail Khattak, Patrick Killorn, Claus Keller, Isabelle Schenkenberger, Stefan Zielen, Sabine Ballenberger, Martin Hoffmann, Joachim Kirschner, Márta Papp, Teréz Kecskés, Magdolna Póczi, Lajos Molnár, Éva Radeczky, Judit Schlezák, Ewa Springer, Violetta Balicka, Jadwiga Kaczmarek, Danuta Madra-Rogacka, Ewa Pisarczyk-Bogacka, Malgorzata Zurowska-Gebala, Maciej Marczak, Piotr Napora, Witold Pomiecko, Erika Pribulova, Svetlana Kurthova, Maria Drugdova, Denisa Kavkova, Luboslava Frajtova, Alexander Golubov, Dagmar Paulinyova, Daniela Hasicova, Miriam Michalickova, Miguel Trevino, Charles Campbell, Andrew Wachtel, Eugene Bleecker, Craig LaForce, David Bernstein, Selwyn Spangenthal, Edward Kerwin, Lyndon Mansfield, Paul Ratner, Samir Arora, Gregory Feldman, Benedict Okwara, Humberto Cruz, Lawrence Sher, Andrew Pedinoff & Clinton Corder. (2017) Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine 5:7, pages 568-576.
Crossref
Crossref
Ke Zhang, Jeffrey Liu, Thao Truong, Elyssa Zukin, Wendy Chen & Andrew Saxon. (2017) Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies. The Journal of Immunology 198:10, pages 3823-3834.
Crossref
Crossref
Sheenal V. Patel & David A. Khan. (2017) Adverse Reactions to Biologic Therapy. Immunology and Allergy Clinics of North America 37:2, pages 397-412.
Crossref
Crossref
Ulrich M. Zissler. 2017. Allergy Prevention and Exacerbation. Allergy Prevention and Exacerbation
209
238
.
A. Le Borgne-Krams, L. Guilleminault, C. Mailhol & A. Didier. (2016) Traitement par anti-IL-5 dans l’asthme sévère : vers la guerre des mabs ?. Revue Française d'Allergologie 56:7-8, pages 549-555.
Crossref
Crossref
Zhengmin Liang, Haiying Nie, Yangfeng Xu, Jianbo Peng, Yun Zeng, Yingyi Wei, Xuemei Wen, Jiaming Qiu, Weiting Zhong, Xuming Deng & Jiakang He. (2016) Therapeutic effects of rosmarinic acid on airway responses in a murine model of asthma. International Immunopharmacology 41, pages 90-97.
Crossref
Crossref
Eugene R Bleecker, J Mark FitzGerald, Pascal Chanez, Alberto Papi, Steven F Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström & Mitchell Goldman. (2016) Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. The Lancet 388:10056, pages 2115-2127.
Crossref
Crossref
J Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T Ferguson, William W Busse, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Viktoria Werkström, Magnus Aurivillius & Mitchell Goldman. (2016) Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet 388:10056, pages 2128-2141.
Crossref
Crossref